文献速递胸部肿瘤放疗放疗物理与技术

咖啡酸苯乙酯(CAPE)作为一种天然多酚可拓宽肺腺癌的治疗窗

Caffeic Acid Phenethyl Ester (CAPE), a natural polyphenol to increase the therapeutic window for lung adenocarcinomas.
PubMed 文献 · Radiother Oncol · 2023-11-22

本研究在肺癌细胞系及正常肺组织(离体精准切割肺切片)中探讨天然多酚咖啡酸苯乙酯(CAPE)的放射增敏与放射保护作用。CAPE 以剂量依赖方式降低细胞活力(IC50 57.6 ± 16.6 μM),在肺腺癌细胞系中显著增加放射敏感性(p < 0.05),而在非腺癌细胞系中未见差异(p ≥ 0.13)。CAPE 还使细胞呼吸向糖酵解偏移(p < 0.01)并诱导线粒体膜去极化(p < 0.01),在腺癌中降低 NF-κB 活性并减少肺切片中促炎基因表达。作者认为 CAPE 联合放疗可能是拓宽肺癌患者治疗窗的潜在有效方法。

要点

  • CAPE 以剂量依赖方式降低肺癌细胞活力,IC50 为 57.6 ± 16.6 μM。
  • CAPE 在肺腺癌细胞系中显著增加放射敏感性(p < 0.05),非腺癌细胞系未见差异(p ≥ 0.13)。
  • CAPE 使细胞呼吸向糖酵解偏移(p < 0.01)并诱导线粒体膜去极化(p < 0.01),在腺癌中降低 NF-κB 活性。

核心结论

  • CAPE 联合放疗可能是拓宽肺癌患者治疗窗的潜在有效方法。

研究设计与样本

  • 研究在肺癌细胞系中体外评估 CAPE 的细胞毒性与放射增敏作用,并使用精准切割肺切片(PCLS)在体外和离体评估其放射保护作用。

主要发现

  • CAPE 以剂量依赖方式降低细胞活力,IC50 为 57.6 ± 16.6 μM。
  • 克隆形成存活实验显示 CAPE 在肺腺癌细胞系中显著增加放射敏感性(p < 0.05),而在非腺癌细胞系中未见差异(p ≥ 0.13)。
  • 细胞周期分析显示,在大多数细胞系中孵育 CAPE 后 S 期增加(p < 0.05)。
  • 代谢谱分析显示 CAPE 使细胞呼吸向糖酵解偏移(p < 0.01),并伴随线粒体膜去极化(p < 0.01)。
  • CAPE 在腺癌中诱导 NF-κB 活性降低,并减少 PCLS 中促炎基因表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Lung cancers are highly resistant to radiotherapy, necessitating the use of high doses, which leads to radiation toxicities such as radiation pneumonitis and fibrosis. Caffeic Acid Phenethyl Ester (CAPE) has been suggested to have anti-proliferative and pro-apoptotic effects in tumour cells, while radioprotective anti-inflammatory and anti-oxidant effects in the normal tissue. We investigated the radiosensitizing and radioprotective effects of CAPE in lung cancer cell lines and normal tissue in vitro and ex vivo, respectively. MATERIALS AND METHODS: The cytotoxic and radiosensitizing effects of CAPE in lung cancer were investigated using viability and clonogenic survival assays. The radioprotective effects of CAPE were assessed in vitro and ex vivo using precision cut lung slices (PCLS). Potential underlying molecular mechanisms of CAPE focusing on cell cycle, cell metabolism, mitochondrial function and pro-inflammatory markers were investigated. RESULTS: Treatment with CAPE decreased cell viability in a dose-dependent manner (IC50 57.6 ± 16.6 μM). Clonogenic survival assays showed significant radiosensitization by CAPE in lung adenocarcinoma lines (p < 0.05), while no differences were found in non-adenocarcinoma lines (p ≥ 0.13). Cell cycle analysis showed an increased S-phase (p < 0.05) after incubation with CAPE in the majority of cell lines. Metabolic profiling showed that CAPE shifted cellular respiration towards glycolysis (p < 0.01), together with mitochondrial membrane depolarization (p < 0.01). CAPE induced a decrease in NF-κB activity in adenocarcinomas and decreased pro-inflammatory gene expression in PCLS. CONCLUSION: The combination of CAPE and radiotherapy may be a potentially effective approach to increase the therapeutic window in lung cancer patients.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Prades-Sagarra E, Laarakker F, Dissy J, et al. Caffeic Acid Phenethyl Ester (CAPE), a natural polyphenol to increase the therapeutic window for lung adenocarcinomas. Radiother Oncol. 2023. PMID: 38000688. doi:10.1016/j.radonc.2023.110021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。